Dysphagia Knowledge Hub — 吞嚥困難知識庫
Refeeding Syndrome in Malnourished Dysphagia Patients
Refeeding syndrome is a life-threatening metabolic complication that can occur when nutritional support — enteral or parenteral — is introduced too rapidly following a period of starvation or severe malnutrition. Though first described in prisoners of war and famine survivors in the 1940s, refeeding syndrome remains a present-day clinical hazard in hospitalised patients with dysphagia, particularly those who have had prolonged periods of reduced or absent oral intake while awaiting safe swallowing assessment or enteral feeding establishment. Clinicians managing dysphagia patients must understand the mechanism, risk stratification criteria, monitoring requirements, and nutritional escalation protocol to prevent refeeding deaths.
Pathophysiology: Hypophosphataemia as the Central Event
In prolonged starvation, the body adapts metabolically to low carbohydrate availability: fat and protein become the predominant energy substrates, insulin secretion falls, and intracellular electrolytes — phosphate, potassium, and magnesium — shift extracellularly. Serum levels of these electrolytes may appear normal on admission despite severe total body depletion, because intracellular deficits are not reflected in plasma concentrations.
When carbohydrate is reintroduced, insulin secretion rises sharply in response to glucose. Insulin drives cellular uptake of glucose and its co-transporters, including phosphate, potassium, and magnesium. This sudden shift of electrolytes from extracellular to intracellular compartments produces acute hypophosphataemia — the hallmark and primary driver of refeeding syndrome.
Phosphate is the key element: it is essential for ATP synthesis, 2,3-diphosphoglycerate production (oxygen delivery to tissues), membrane phospholipids, and cellular signalling. Acute serum phosphate falls to below 0.5–0.6 mmol/L can produce: cardiac arrhythmias and heart failure, respiratory muscle failure (ventilator dependency), seizures, delirium, haemolytic anaemia, rhabdomyolysis, and peripheral neuropathy. Severe refeeding syndrome is rapidly fatal if not recognised and managed.
Concurrent hypokalaemia (from insulin-driven K+ shift and urinary losses) and hypomagnesaemia (from poor absorption and intracellular shift) compound the cardiac risk. Thiamine (vitamin B1) deficiency — often pre-existing in chronically malnourished patients — is unmasked by glucose refeeding, as thiamine is the rate-limiting cofactor for pyruvate dehydrogenase in carbohydrate metabolism; deficiency produces Wernicke’s encephalopathy.
NICE Risk Criteria
The National Institute for Health and Care Excellence (NICE) guideline CG32 (2006) defines high-risk criteria for refeeding syndrome that are widely used in HK hospitals as the clinical standard:
High risk if ONE or more of the following:
- BMI <16 kg/m²
- Unintentional weight loss >15% over the preceding 3–6 months
- Minimal or no nutritional intake for >10 consecutive days
- Serum phosphate, potassium, or magnesium below normal range before feeding
High risk if TWO or more of the following:
- BMI <18.5 kg/m²
- Unintentional weight loss >10% over 3–6 months
- Minimal or no nutritional intake for >5 days
- History of chronic alcohol use, insulin therapy, antacid use, or chemotherapy (all interfere with phosphate/electrolyte balance)
In the dysphagia context, patients at highest refeeding risk include: older adults with head and neck cancer post-treatment on prolonged NGT feeding; patients with ALS or progressive neurological dysphagia who have had extended periods of reduced intake before PEG placement; post-stroke patients who were NPO for >10 days in acute care; and any patient with the combination of low BMI and recent acute illness.
Monitoring Protocol: Electrolytes 3x Daily for First 4 Days
For patients identified as high-risk, the monitoring protocol recommended by NICE (2006) and adopted in HK Hospital Authority guidelines is:
Electrolytes (phosphate, potassium, magnesium, sodium) and glucose: three times daily for the first four days of nutritional support, then daily for the following three to four days, then every 48–72 hours if stable.
Additional monitoring includes:
- Fluid balance: strict daily input/output chart
- Weight: daily during the first week
- 12-lead ECG: baseline and with any electrolyte abnormality (QTc prolongation is a key risk marker)
- Signs and symptoms: daily clinical review for muscle weakness, confusion, respiratory distress, arrhythmia, and oedema
Frequency is then reduced as electrolytes stabilise and caloric target is reached. In patients with renal impairment, phosphate supplementation must be dose-adjusted to avoid hyperphosphataemia.
Thiamine Replacement Protocol
Thiamine must be replaced BEFORE introducing carbohydrate in high-risk patients. This is a non-negotiable principle: administering glucose to a thiamine-deficient patient before repleting thiamine can precipitate acute Wernicke’s encephalopathy.
NICE CG32 recommends:
- High-risk patients: thiamine 200–300 mg orally (or IV if oral route unavailable) once daily for at least 10 days before and during refeeding
- When IV route is required (e.g., obtunded patient, dysphagia preventing oral supplementation): Pabrinex intravenous high potency ampoules (thiamine 250 mg + other B vitamins) once daily, or thiamine 100 mg IV over 30 minutes, for the first 3–5 days
In HK hospitals, thiamine replacement in refeeding-risk patients is routinely ordered by dietitians in collaboration with medical teams. SLTs initiating early oral intake after prolonged NPO should flag refeeding risk for dietitian review before commencing.
Phosphate and Potassium Targets
Target ranges during refeeding:
- Phosphate: 0.8–1.4 mmol/L (oral supplementation with Phosphate-Sandoz or equivalent for mild-moderate depletion; IV replacement for serum <0.4 mmol/L or symptomatic hypophosphataemia)
- Potassium: 3.5–5.0 mmol/L (oral KCl supplementation first-line; IV replacement if serum <2.5 mmol/L or arrhythmia present)
- Magnesium: 0.7–1.0 mmol/L (oral magnesium glycerophosphate for mild deficiency; IV magnesium sulphate for severe deficiency or symptomatic cases)
Electrolyte supplementation during refeeding is given concurrently with nutritional support, not as a prerequisite for feeding. The goal is to maintain target ranges while slowly escalating nutrition, not to defer feeding until electrolytes normalise independently.
Gradual Caloric Escalation Formula
The foundational principle of refeeding syndrome prevention is starting caloric intake low and advancing slowly, allowing time for electrolyte equilibration.
NICE-recommended initial caloric target for high-risk patients:
- Start at 10 kcal/kg/day (approximately 500–700 kcal/day for most adults) for the first two days
- Advance by 10 kcal/kg every 2 days if electrolytes are stable
- Aim to reach full caloric target (25–35 kcal/kg/day) by Day 5–7
For severely malnourished patients (BMI <14 or weight loss >20%), an even more cautious start of 5 kcal/kg/day is recommended, with biweekly advancement.
In the dysphagia context, this applies to:
- Initiation of NGT or PEG tube feeding after prolonged NPO
- Resumption of oral intake after prolonged reduced intake (where oral calories were negligible)
- Post-operative refeeding in head and neck cancer patients
Protein: high-risk patients still require adequate protein (1.2–1.5 g/kg/day) from the outset; protein restriction is not required in refeeding syndrome (it is primarily a carbohydrate-energy-driven phenomenon).
Practical Application in Dysphagia Dietetics
For dietitians and clinicians managing dysphagia patients on NGT feeds in ward or residential settings:
- Screen all patients commencing tube feeding against NICE risk criteria
- Document pre-feeding electrolytes (phosphate, potassium, magnesium, urea, creatinine, glucose)
- Order prophylactic thiamine before starting any carbohydrate-containing formula
- Prescribe initial formula at 10 kcal/kg/day; ensure ward staff understand this is deliberate
- Establish electrolyte monitoring schedule in drug chart or nursing care plan
- Define escalation plan: who to call and at what electrolyte threshold
- Communicate risk to family/caregivers who may pressure staff for faster intake escalation
References
- Hearing SD. (2004). Refeeding syndrome. BMJ, 328(7445), 908–909.
- Kraft MD, Btaiche IF, Sacks GS. (2005). Review of the refeeding syndrome. Nutrition in Clinical Practice, 20(6), 625–633.
- National Institute for Health and Care Excellence (NICE). (2006). Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition. Clinical Guideline CG32. London: NICE.
- Rio A, Whelan K, Goff L, et al. (2013). Occurrence of refeeding syndrome in adults started on artificial nutrition support: prospective cohort study. BMJ Open, 3(1), e002173.
- Solomon SM, Kirby DF. (1990). The refeeding syndrome: a review. Journal of Parenteral and Enteral Nutrition, 14(1), 90–97.